Premium
Modulation of Wnt and Hedgehog Signaling Pathways Is Linked to Retinoic Acid‐Induced Amelioration of Chronic Allograft Dysfunction
Author(s) -
von Toerne C.,
Bedke J.,
Safi S.,
Porubsky S.,
Gretz N.,
Loewe R.,
Nelson P. J.,
Gröne H.J.
Publication year - 2012
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2011.03776.x
Subject(s) - wnt signaling pathway , retinoic acid , fibrosis , medicine , hedgehog signaling pathway , sonic hedgehog , cancer research , hedgehog , tacrolimus , signal transduction , microbiology and biotechnology , endocrinology , biology , transplantation , genetics , gene
Chronic renal allograft damage (CAD) is manifested by a smoldering inflammatory process that leads to transplant glomerulopathy, diffuse interstitial fibrosis and tubular atrophy with loss of tubular structures. Using a Fischer 344 (RT1lvl) to Lewis (RT1l) rat renal allograft model, transcriptomic profiling and pathway mapping, we have previously shown that dynamic dysregulation of the Wnt signaling pathways may underlie progressive CAD. Retinoic acid, an important regulator of differentiation during vertebrate embryogenesis, can moderate the damage observed in this experimental model of CAD. We show here that subsets of the Hedgehog (Hh) and canonical Wnt signaling pathways are linked to the pathophysiology of progressive fibrosis, loss of cilia in epithelia and chronic dysfunction. Oral treatment with 13cis retinoic acid (13cRA) was found to selectively ameliorate the dysregulation of the Hh and canonical Wnt pathways associated with CAD, and lead to a general preservation of cilial structures. Interplay between these pathways helps explain the therapeutic effects of retinoic acid treatment in CAD, and suggests future targets for moderating chronic fibrosing organ damage.